When does combining markers improve classification performance and what are implications for practice?
Author:
Affiliation:
1. Department of Biostatistics; University of Washington; Campus Mail Stop 359461 Seattle WA 98195 U.S.A.
2. Biostatistics and Biomathematics; Fred Hutchinson Cancer Research Center; 1100 Fairview Avenue North M2-B500 Seattle WA 98109 U.S.A.
Funder
National Institutes of Health
Publisher
Wiley
Subject
Statistics and Probability,Epidemiology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/sim.5736/fullpdf
Reference13 articles.
1. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker;Pepe;Americal Journal of Epidemiology,2004
2. Assessing lead time of selected ovarian cancer biomarkers: a nested case-control study;Anderson;Journal of the National Cancer Institute,2010
3. Discriminatory accuracy from single-nucleotide polymorphisms in models to predict breast cancer risk;Gail;Journal of the National Cancer Institute,2008
4. Combining several screening tests: optimality of the risk score;McIntosh;Biometrics,2002
5. On the problem of the most efficient tests of statistical hypotheses;Neyman;Philosophical Transactions of the Royal Society London A,1933
Cited by 31 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparing the Min–Max–Median/IQR Approach with the Min–Max Approach, Logistic Regression and XGBoost, Maximising the Youden Index;Symmetry;2023-03-19
2. HiPerMAb: a tool for judging the potential of small sample size biomarker pilot studies;The International Journal of Biostatistics;2023-03-06
3. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer;Journal of Oncology;2022-11-23
4. Performance of diagnostic tests based on continuous bivariate markers;Journal of Applied Statistics;2022-10-26
5. PTPRO-related CD8+ T-cell signatures predict prognosis and immunotherapy response in patients with breast cancer;Frontiers in Immunology;2022-08-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3